The Male Bias in the Number of Purkinje Cells and the Size of the Murine Cerebellum may Require Müllerian Inhibiting Substance/Anti-Müllerian Hormone

Journal of Neuroendocrinology

Volumn 23, Issue 9, 2011, Pages 831-838

  Wittmann, W ^a   Mclennan, I S ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Childhood; Sexual dimorphism; Testes; Type II mis receptor

Indexed keywords

MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CEREBELLUM; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SEX DIFFERENCE;

ANIMALS; ANTI-MULLERIAN HORMONE; CEREBELLUM; FEMALE; MALE; MICE; MICE, KNOCKOUT; PURKINJE CELLS; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 80051557697     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02187.x     Document Type: Article

References (52)

1. Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS Jr, Faraone SV, Tsuang MT. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex 2001; 11: 490-497.
2. Holden C. Sex and the suffering brain. Science 2005; 308: 1574-1577.
3. Dean SL, McCarthy MM. Steroids, sex and the cerebellar cortex: implications for human disease. Cerebellum 2008; 7: 38-47.
4. Wudy SA, Dorr HG, Solleder C, Djalali M, Homoki J. Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentraions in fetuses at risk for 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 2724-2728.
5. Wudy SA, Wachter UA, Homoki J, Teller WM. 17alpha-hydroxyprogesterone, 4-androstenedione and testosterone profiled by routine stable isotope dilution/gas chromatography-mass spectrometry of children. Pediatr Res 1995; 38: 76-80.
6. Teixeira J, Maheswaran S, Donahoe PK. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 2001; 22: 657-674.
7. Forger NG. Control of cell number in the sexually dimorphic brain and spinal cord. J Neuroendocrinol 2009; 21: 393-399.
8. MacLaughlin DT, Donahoe PK. Sex determination and differentiation. N Engl J Med 2004; 350: 367-378.
9. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996; 81: 571-576.
10. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebaek NE, Juul A. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010; 95: 5357-5364.
11. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700.
12. Wang PY, Koishi K, McGeachie AB, Kimber M, MacLaughlin DT, Donahoe PK, McLennan IS. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci USA 2005; 102: 16421-16425.
13. Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci USA 2009; 106: 7203-7208.
14. Lebeurrier N, Launay S, Macrez R, Maubert E, Legros H, Leclerc A, Jamin SP, Picard JY, Marret S, Laudenbach V, Berger P, Sonderegger P, Ali C, di Clemente N, Vivien D. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. J Cell Sci 2008; 121: 3357-3365.
15. Raz N, Dupuis JH, Briggs SD, McGavran C, Acker JD. Differential effects of age and sex on the cerebellar hemispheres and the vermis: a prospective MR study. AJNR Am J Neuroradiol 1998; 19: 65-71.
16. Chung SC, Lee BY, Tack GR, Lee SY, Eom JS, Sohn JH. Effects of age, gender, and weight on the cerebellar volume of Korean people. Brain Res 2005; 1042: 233-235.
17. Raz N, Ghisletta P, Rodrigue KM, Kennedy KM, Lindenberger U. Trajectories of brain aging in middle-aged and older adults: regional and individual differences. Neuroimage 2010; 51: 501-511.
18. Tiemeier H, Lenroot RK, Greenstein DK, Tran L, Pierson R, Giedd JN. Cerebellum development during childhood and adolescence: a longitudinal morphometric MRI study. Neuroimage 2010; 49: 63-70.
19. Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL, Castellanos FX. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 1998; 50: 1087-1093.
20. Mackie S, Shaw P, Lenroot R, Pierson R, Greenstein DK, Nugent TF III, Sharp WS, Giedd JN, Rapoport JL. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiatry 2007; 164: 647-655.
21. Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain 2004; 127: 2572-2583.
22. Gillig PM, Sanders RD. Psychiatry, neurology, and the role of the cerebellum. Psychiatry (Edgmont) 2010; 7: 38-43.
23. Altman J, Bayer SA. Embryonic development of the rat cerebellum. III. Regional differences in the time of origin, migration, and settling of Purkinje cells. J Comp Neurol 1985; 231: 42-65.
24. Marti J, Wills KV, Ghetti B, Bayer SA. Regional differences in the Purkinje cells settled pattern: a comparative autoradiographic study in control and homozygous weaver mice. Exp Neurol 2002; 175: 168-181.
25. Weisz J, Ward IL. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology 1980; 106: 306-316.
26. Chen H, Geb R-S, Zirkina BR. Leydig cells: from stem cells to aging. Mol Cell Endocrinol 2009; 306: 9-16.
27. Al-Attar L, Noel K, Dutertre M, Belville C, Forest MG, Burgoyne PS, Josso N, Rey R. Hormonal and cellular regulation of Sertoli cell anti-Mullerian hormone production in the postnatal mouse. J Clin Invest 1997; 100: 1335-1343.
28. Motelica-Heino I, Castanier M, Corbier P, Edwards DA, Roffi J. Testosterone levels in plasma and testes of neonatal mice. J Steroid Biochem 1988; 31: 283-286.
29. Jean-Faucher C, Berger M, de Turckheim M, Veyssiere G, Jean C. Developmental patterns of plasma and testicular testosterone in mice from birth to adulthood. Acta Endocrinol 1978; 89: 780-788.
30. Madalosso SH, Perez-Villegas EM, Armengol JA. Naturally occurring neuronal death during the postnatal development of Purkinje cells and their precerebellar afferent projections. Brain Res Rev 2005; 49: 267-279.
31. Behringer RR, Finegold MJ, Cate RL. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994; 79: 415-425.
32. McLennan IS, Taylor-Jeffs J. The use of sodium lamps to brightly illuminate mouse houses during their dark phases. Lab Anim 2004; 38: 1-9.
33. Wang PY, Koishi K, McLennan IS. BMP6 is axonally transported by motoneurons and supports their survival in vitro. Mol Cell Neurosci 2007; 34: 653-661.
34. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 2002; 32: 408-410.
35. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
36. Russell FD, Koishi K, Jiang Y, McLennan IS. Anterograde axonal transport of glial cell line-derived neurotrophic factor and its receptors in rat hypoglossal nerve. Neuroscience 2000; 97: 575-580.
37. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96: 857-881.
38. Hall AK, Miller RH. Emerging roles for bone morphogenetic proteins in central nervous system glial biology. J Neurosci Res 2004; 76: 1-8.
39. Doulazmi M, Frederic F, Lemaigre-Dubreuil Y, Hadj-Sahraoui N, Delhaye-Bouchaud N, Mariani J. Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora(+)/Rora(sg)) is gender-related. J Comp Neurol 1999; 411: 267-273.
40. Wu X, Arumugam R, Baker SP, Lee MM. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice. Endocrinology 2005; 146: 589-595.
41. Qin L, Wine-Lee L, Ahn KJ, Crenshaw EB III. Genetic analyses demonstrate that bone morphogenetic protein signaling is required for embryonic cerebellar development. J Neurosci 2006; 26: 1896-1905.
42. Barneda-Zahonero B, Minano-Molina A, Badiola N, Fado R, Xifro X, Saura CA, Rodriguez-Alvarez J. Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway. Mol Biol Cell 2009; 20: 5051-5063.
43. Zhang D, Mehler MF, Song Q, Kessler JA. Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J Neurosci 1998; 18: 3314-3326.
44. Chen S, Hillman DE. Regulation of granule cell number by a predetermined number of purkinje cells in development. Brain Res Dev Brain Res 1989; 45: 137-148.
45. Giedd JN, Rapoport JL. Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 2010; 67: 728-734.
46. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, Leger J, Porquet D, Noel M. Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003; 211: 55-63.
47. Morgan K, Dennis NA, Ruffman T, Bilkey DK, McLennan IS. The stature of boys is inversely correlated to the levels of their Sertoli cell hormones: do the testes restrain the maturation of boys? PLoS ONE 2011; 6: e20533.
48. Nowell A, Hedges LV. Trends in gender differences in academic achievement from 1960 to 1994: an analysis of differences in mean, variance and extreme scores. Sex Roles 1998; 39: 21-43.
49. Penner AM, Paret M. Gender differences in mathematics achievement: exploring the early grades and the extremes. Soc Sci Res 2008; 37: 239-253.
50. Clarkson AN, Talbot CL, Wang PY, Maclaughlin DT, Donahoe PK, McLennan IS. Mullerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons. Exp Neurol 2011; in press: PMID: 21195071.
51. Racine C, Rey R, Forest MG, Louis F, Ferre A, Huhtaniemi I, Josso N, di Clemente N. Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 1998; 95: 594-599.
52. Morgan K, Meredith J, Kuo J-Y, Bilkey DK, McLennan IS. The sex bias in novelty preference of preadolescent mouse pups may require testicular Müllerian inhibiting substance. Behav Brain Res 2011; 221: 304-306.